The EGFR signaling pathway plays a critical role in DMD by modulating FAP and myoblast behavior contributing to fibrotic and adipogenic tissue expansion, as well as impaired muscle regeneration. The gene discussed is FAP; the disease is Duchenne muscular dystrophy.